Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CalciMedica Inc CALC

Healthcare
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora... see more

NDAQ:CALC - Post Discussion

CalciMedica Inc > Graycliff Exploration CEO Update: WATCH AND READ
View:
Post by yukon_gold on Mar 09, 2023 8:43pm

Graycliff Exploration CEO Update: WATCH AND READ

 
 
CEO Update:
 
Progress at Shakespeare and Baldwin and New Lunge Acquisition
 
 
We thought we were due for an update, so we recorded CEO James Macintosh talking about Graycliff's project portfolio, past milestones and upcoming catalysts, and then we did the written version so you can pick and choose -- or watch and read both.
 
Click here or on the video above to watch
 
Click here or on the image above to read
 
 
We invite you to contact us anytime with questions and comments!
 
 
 
For more information, please contact:
 
Investor Relations
1-647-249-9298
 
Graycliff Exploration | 401 Bay Street, Suite 2702, 401 Bay Street, Suite 2702, Toronto, M5H2Y4 Canada
Be the first to comment on this post
CalciMedica Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities